Abstract
A structure–binding activity relationship for the intestinal bile acidtransporter has been developed using data from a series of bile acid analogsin a comparative molecular field analysis (CoMFA). The studied compoundsconsisted of a series of bile acid–peptide conjugates, withmodifications at the 24 position of the cholic acid sterol nucleus, andcompounds with slight modifications at the 3, 7, and 12 positions. For theCoMFA study, these compounds were divided into a training set and a test set,comprising 25 and 5 molecules, respectively. The best three-dimensionalquantitative structure–activity relationship model found rationalizesthe steric and electrostatic factors which modulate affinity to the bile acidcarrier with a cross-validated, conventional and predictive r2of 0.63, 0.96, and 0.69, respectively, indicating a good predictive model forcarrier affinity. Binding is facilitated by positioning an electronegativemoiety at the 24–27 position, and also by steric bulk at the end of theside chain. The model suggests substitutions at positions 3, 7, 12, and 24that could lead to new substrates with reasonable affinity for the carrier.
Similar content being viewed by others
References
Johnson, L. (Ed.) Physiology of the Gastrointestinal Tract, 2nd ed., Raven Press, New York, NY, U.S.A., 1987, pp. 1557–1580.
Swaan, P.W., Szoka Jr., F.C. and Øie, S., Adv. Drug Deliv. Rev., 20 (1996) 59.
Kramer, W., Burckhardt, G., Wilson, F.A. and Kurz, G., J. Biol. Chem., 258 (1983) 3623.
Lin, M.C., Kramer, W. and Wilson, F.A., J. Biol. Chem., 265 (1990) 14986.
Lin, M.C., Weinberg, S.L., Kramer, W., Burckhardt, G. and Wilson, F.A., J. Membr. Biol., 106 (1988) 1.
Burckhardt, G., Kramer, W., Kurz, G. and Wilson, F.A., J. Biol. Chem., 258 (1983) 3618.
Schiff, E.R., Small, N.C. and Dietschy, J.M., J. Clin. Invest., 51 (1972) 1351.
Heaton, K.W. and Lack, L., Am. J. Physiol., 214 (1968) 585.
Kramer, W., Wess, G., Neckermann, G., Schubert, G., Fink, J., Girbig, F., Gutjahr U., Kowalewski, S., Baringhaus, K.H. and Boger, G., J. Biol. Chem., 269 (1994) 10621.
Wess, G., Kramer, W., Enhsen, A., Glombik, H., Baringhaus, K.H., Boger, G., Urmann, M., Bock, K., Kleine, H., Neckermann, G., Hoffmann, A., Pittius, C., Falk, E., Fehlhaber, H.W., Kogler, H. and Friedrich, M., J. Med. Chem., 37 (1994) 873.
Cramer III, R.D., Patterson, D. and Bunce, J., J. Am. Chem. Soc., 110 (1988) 5959.
Recanatini, M., J. Comput.-Aided Mol. Design, 10 (1996) 74.
Tong, W., Collantes, E.R., Chen, Y. and Welsh, W.J., J. Med. Chem., 39 (1996) 380.
Siddiqi, S.M., Pearlstein, R.A., Sanders, L.H. and Jacobson, K.A., Bioorg. Med. Chem., 3 (1995) 1331.
Kubinyi, H. (Ed.) 3D QSAR in Drug Design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993.
Kågedahl, M., Swaan, P.W., Redemann, C.T., Tang, M., Craik, C.S., Szoka Jr., F.C. and Øie, S., Pharm. Res., 14 (1997) 176.
Swaan, P.W., Hillgren, K.M., Szoka Jr., F.C. and Øie, S., Bioconj. Chem., 8 (1997) 520.
Kramer, W. and Schneider, S., J. Lipid Res., 30 (1989) 1281.
Schneider, S., Schramm, U., Schreyer, A., Buscher, H.-P., Gerok, W. and Kurz, G., J. Lipid Res., 32 (1991) 1755.
SYBYL v. 6.3, Tripos Associates, St. Louis, MO, U.S.A.
Miki, K., Kasai, N., Shibakami, M., Chirachanchai, S., Takemoto, K. and Miyata, M., Acta Crystallogr., C46 (1990) 2442.
Campanelli, A.R., de Sanctis, S.C., D’Archivio, A.A., Giglio, E. and Scaramuzza, L., J. Incl. Phen., 11 (1991) 247.
MOPAC 6.0, Quantum Chemistry Exchange Program, No. 455.
Daylight software package, release 4.4, Daylight Chemical Information Systems Inc., Mission Viejo, CA, U.S.A.
SYSTAT, SPSS Inc. Chicago, IL, U.S.A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swaan, P.W., Jr., F.C.S. & Øie, S. Molecular modeling of the intestinal bile acid carrier: A comparative molecular field analysis study. J Comput Aided Mol Des 11, 581–588 (1997). https://doi.org/10.1023/A:1007919704457
Issue Date:
DOI: https://doi.org/10.1023/A:1007919704457